The Nova Protocol: a comprehensive multimodal longitudinal study among civilian survivors of a mass trauma event.
Roee Admon, Ophir Netzer, Noa Magal, Lisa Simon, Amir Harduf, Michal Oren, Omri Radai, Stephanie Keren Cohen, Meital Bobek, Mary Grankin, Ron Menshes, Yonatan Stern, Noga Mandelblit, Avraham Shmueli, Eden Eldar, Daniel Sand, Tzuk Polinsky, Raz Gross, Roy Salomon
European Journal of Psychotraumatology September 14, 2026 DOI: 10.1080/20008066.2026.2721729 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Longitudinal observational study protocol Qualitative Peer reviewed |
|---|---|
| Population | Survivors of the 7 October 2023 Nova music festival attack and a sociocultural comparison group |
| Duration | From the first weeks to approximately 24 months post-trauma, with three major assessment time points |
| Measures | PCL-5, K6 |
| Topics | MDMA PTSD |
| Keywords | Tept Ecological assessment Estudio longitudinal Evaluación ecológica Longitudinal study Mass-trauma Psychedelics Psychoactive substances Sensores portátiles Sustancias psicoactivas Trauma masivo Wearable sensors |
| Key findings | The paper describes the rationale, design, and methodology of the Nova Protocol, a multimodal longitudinal observational study that will characterize psychological, behavioural, physiological, inflammatory, neural, interoceptive, and subjective mechanisms shaping clinical trajectories after civilian mass trauma. The authors state that because psychoactive substance exposure was naturalistic and self-selected, findings will be interpreted as mechanistic and prognostic associations rather than causal effects, and are expected to inform early risk detection and scalable post-disaster monitoring and intervention strategies. |
Abstract
Background: The 7 October 2023 attack in southern Israel was one of the deadliest terror attacks in modern history, with 1,182 fatalities, more than 4,000 wounded individuals, and 251 hostages. The Nova music festival, an all-night outdoor rave near the Gaza border, suffered the highest number of civilian casualties, with more than 370 festival attendees killed. Survivors were exposed to prolonged life-threatening trauma with similar characteristics and within a narrow time window. Many survivors also reported being under the acute influence of psychoactive substances during the attack and the following hours. This tragic combination of civilian mass trauma and naturalistic pharmacological exposure provided a rare opportunity to study trauma processing prospectively.Objective: This paper describes the rationale, design, and methodology of the Nova Protocol, a multimodal longitudinal observational study of survivors of the 7 October 2023 Nova festival attack and a sociocultural comparison group.Methods: The protocol spans from the first weeks to approximately 24 months post-trauma and includes three major assessment time points. It integrates repeated online clinical assessments, prolonged wearable-sensor monitoring, ecological assessments, saliva-based endocrine and inflammatory markers, structural and functional MRI, cardiac interoception paradigms, online and in-scanner reinforcement-learning tasks, and semi-structured qualitative interviews. Primary outcomes are PTSD symptom severity (PCL-5) and general psychological distress (K6), supplemented by a rich battery of secondary measures.Conclusion: The Nova Protocol provides an unusually rich longitudinal framework for characterizing psychological, behavioural, physiological, inflammatory, neural, interoceptive, and subjective mechanisms that shape clinical trajectories after civilian mass trauma. Because psychoactive substance exposure was naturalistic and self-selected, findings will be interpreted as mechanistic and prognostic associations rather than causal effects. The protocol is expected to inform early risk detection and scalable post-disaster monitoring and intervention strategies, while also providing unique insights into how psychoactive substances impact trauma processing.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
State of the evidence: PTSD Unclear
Describes a longitudinal multimodal study of trauma survivors intended to characterize mechanisms and trajectories of PTSD symptoms, with naturalistic substance exposure treated as non-causal.
Synthesized
Comparable studies
Other observational and cohort studies on MDMA for PTSD, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder Women with chronic PTSD secondary to sexual assault | 2008 | Observational cohort | n = 6 |
| Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder. Veterans and first-responders with chronic PTSD of 6 months or more | 2022 | Observational cohort | n = 9 |
| Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders German adolescent patients with a substance use disorder | 2021 | Observational cohort | n = 121 |
| Evidence for altered neural activity patterns after MDMA-assisted therapy in adults with chronic and severe post-traumatic stress disorder: a pilot study Veterans and first-responders with PTSD | 2022 | Observational cohort | n = 9 |
Citations in the library
Cites 7
- Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin Journal of Psychopharmacology October 6, 2015
- 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry May 1, 2018
- MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial. Nature Medicine October 1, 2023
- Psychedelics as anti-inflammatory agents International Review of Psychiatry July 4, 2018
- The Prosocial Effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled Studies in Humans and Laboratory Animals Neuroscience & Biobehavioral Reviews September 25, 2015
and 2 more in the library